The store will not work correctly when cookies are disabled.
US9302986, 30
ID: ALA3954408
Chembl Id: CHEMBL3954408
PubChem CID: 118117193
Max Phase: Preclinical
Molecular Formula: C12H17FN2O3S
Molecular Weight: 288.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCNS(=O)(=O)c1ccc(OC/C(=C/F)CN)cc1
Standard InChI: InChI=1S/C12H17FN2O3S/c1-2-15-19(16,17)12-5-3-11(4-6-12)18-9-10(7-13)8-14/h3-7,15H,2,8-9,14H2,1H3/b10-7+
Standard InChI Key: IIWDSUYELQFEAA-JXMROGBWSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.34 | Molecular Weight (Monoisotopic): 288.0944 | AlogP: 1.18 | #Rotatable Bonds: 7 |
Polar Surface Area: 81.42 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.47 | CX Basic pKa: 9.27 | CX LogP: 0.25 | CX LogD: -1.43 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.79 | Np Likeness Score: -1.26 |
References
1. (2016) Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof, |